∼- elemene, a compound derived from Rhizoma zedoariae, reverses multidrug resistance mediated by the ABCB1 transporter

被引:49
|
作者
Guo, Hui-Qin [1 ,2 ]
Zhang, Guan-Nan [2 ]
Wang, Yi-Jun [2 ]
Zhang, Yun-Kai [2 ]
Sodani, Kamlesh [2 ]
Talele, Tanaji T. [2 ]
Ashby, Charles R., Jr. [2 ]
Chen, Zhe-Sheng [2 ]
机构
[1] Beijing Union Med Coll Hosp, Dept Thorac Surg, Beijing 100730, Peoples R China
[2] St Johns Univ, Dept Pharmaceut Sci, Coll Pharm & Hlth Sci, Queens, NY 11439 USA
关键词
ABCB1; multidrug resistance; -elemene; ABCB1-MEDIATED DRUG-RESISTANCE; P-GLYCOPROTEIN ABCB1; CANCER-CELLS; BETA-ELEMENE; TUMOR-CELLS; IN-VITRO; INHIBITORS; BINDING; LINES; VINCRISTINE;
D O I
10.3892/or.2013.2870
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In the present in vitro study, we examined the effect of the compound -elemene on the response of KB-C2 cells overexpressing the ABCB1 transporter to specific antineoplastic compounds. The MTT assay was used to determine the effects of -elemene in combination with other anticancer drugs on ABCB1-overexpressing cancer cell lines. Furthermore, we used [H-3]-paclitaxel accumulation, efflux assay, immunofluorescence experiments, western blot assays and docking analysis to ascertain the mechanism of action of -elemene. The incubation of KB-C2 cells overexpressing ABCB1 transporter with -elemene (100 M) significantly augmented the antineoplastic efficacy of colchicine, vinblastine and paclitaxel when compared to KB-C2 cells incubated with these drugs alone. In HEK293 cells overexpressing the ABCB1 transporter, -elemene significantly increased the cytotoxicity of paclitaxel. In addition, 100 M of -elemene significantly increased the accumulation of [H-3]-paclitaxel and this was due to a decrease in [H-3]-paclitaxel efflux when compared to controls. The incubation of KB-C2 cells with -elemene (100 M) for 72 h did not significantly alter the expression of ABCB1 protein levels. Immunofluorescence experiments indicated that -elemene did not significantly alter the subcellular localization of the ABCB1 transporter. Docking analysis indicated that -elemene binds to the drug-binding site of ABCB1 transporter. Finally, -elemene at 100 M partially (similar to 50%) increased the sensitivity of the BCRP-overexpressing cell line, NCI-H460/MX20, to mitoxantrone, but -elemene did not significantly alter the resistance of MRP1-transfected HEK293/MRP1 cells to vincristine. Overall, our in vitro findings indicated that -elemene potentiates the cytotoxic effects of various antineoplastic drugs in cell lines overexpressing the ABCB1 transporter and that this is due to the inhibition of the efflux component of the ABCB1 transporter.
引用
收藏
页码:858 / 866
页数:9
相关论文
共 50 条
  • [21] Next generation inhibitors to reverse ABCB1 transport mediated multidrug resistance in cancer
    Barbuti, Anna Maria
    Patel, Bhargav A.
    Talele, Tanaji T.
    Chen, Zhe-Sheng
    CANCER RESEARCH, 2016, 76
  • [22] Avapritinib: A Selective Inhibitor of KIT and PDGFRα that Reverses ABCB1 and ABCG2-Mediated Multidrug Resistance in Cancer Cell Lines
    Wu, Chung-Pu
    Lusvarghi, Sabrina
    Wang, Jyun-Cheng
    Hsiao, Sung-Han
    Huang, Yang-Hui
    Hung, Tai-Ho
    Ambudkar, Suresh V.
    MOLECULAR PHARMACEUTICS, 2019, 16 (07) : 3040 - 3052
  • [23] Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene
    Kroetz, DL
    Pauli-Magnus, C
    Hodges, LM
    Huang, CC
    Kawamoto, M
    Johns, SJ
    Stryke, D
    Ferrin, TE
    DeYoung, J
    Taylor, T
    Carlson, EJ
    Herskowitz, I
    Giacomini, KM
    Clark, AG
    PHARMACOGENETICS, 2003, 13 (08): : 481 - 494
  • [24] Association between multidrug resistance in epilepsy and haplotypes in the drug transporter gene ABCB1 in Han Chinese
    Kwan, P.
    Wong, V
    Ng, P.
    Lui, C.
    Sin, N.
    Hui, A.
    Yip, P.
    Yu, E.
    Baum, L.
    EPILEPSIA, 2007, 48 : 128 - 128
  • [25] Characterization and tissue localization of zebrafish homologs of the human ABCB1 multidrug transporter
    Robert W. Robey
    Andrea N. Robinson
    Fatima Ali-Rahmani
    Lyn M. Huff
    Sabrina Lusvarghi
    Shahrooz Vahedi
    Jordan M. Hotz
    Andrew C. Warner
    Donna Butcher
    Jennifer Matta
    Elijah F. Edmondson
    Tobie D. Lee
    Jacob S. Roth
    Olivia W. Lee
    Min Shen
    Kandice Tanner
    Matthew D. Hall
    Suresh V. Ambudkar
    Michael M. Gottesman
    Scientific Reports, 11
  • [26] Isobavachalcone as an Active Membrane Perturbing Agent and Inhibitor of ABCB1 Multidrug Transporter
    Palko-Labuz, Anna
    Blaszczyk, Maria
    Sroda-Pomianek, Kamila
    Wesolowska, Olga
    MOLECULES, 2021, 26 (15):
  • [27] Characterization and tissue localization of zebrafish homologs of the human ABCB1 multidrug transporter
    Robey, Robert W.
    Robinson, Andrea N.
    Ali-Rahmani, Fatima
    Huff, Lyn M.
    Lusvarghi, Sabrina
    Vahedi, Shahrooz
    Hotz, Jordan M.
    Warner, Andrew C.
    Butcher, Donna
    Matta, Jennifer
    Edmondson, Elijah F.
    Lee, Tobie D.
    Roth, Jacob S.
    Lee, Olivia W.
    Shen, Min
    Tanner, Kandice
    Hall, Matthew D.
    Ambudkar, Suresh, V
    Gottesman, Michael M.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [28] LRIG1, human EGFR inhibitor, reverses multidrug resistance through modulation of ABCB1 and ABCG2
    Liu, Baohui
    Guo, Zhentao
    Dong, Huimin
    Tian, Daofeng
    Cai, Qiang
    Ji, Baowei
    Zhang, Shenqi
    Wu, Liquan
    Wang, Junmin
    Wang, Long
    Zhu, Xiaonan
    Liu, Yue
    Chen, Qianxue
    BRAIN RESEARCH, 2015, 1611 : 93 - 100
  • [29] POLYMORPHISMS OF MULTIDRUG RESISTANCE TRANSPORTER (ABCG2 AND ABCB1) GENES IN PATIENTS WITH ACUTE MYELOID LEUKAEMIA
    Andrikovics, H.
    Koszarska, M.
    Bors, A.
    Papp, N.
    Czifra, D.
    Csacsovszki, O.
    Batai, A.
    Adam, E.
    Kozma, A.
    Lovas, N.
    Sipos, A.
    Dolgos, J.
    Fekete, S.
    Remenyi, P.
    Sarkadi, B.
    Tordai, A.
    Masszi, T.
    HAEMATOLOGICA, 2013, 98 : 402 - 402
  • [30] SuperNatural inhibitors to reverse multidrug resistance emerged by ABCB1 transporter: Database mining, lipid-mediated molecular dynamics, and pharmacokinetics study
    Ibrahim, Mahmoud A. A.
    Abdeljawaad, Khlood A. A.
    Abdelrahman, Alaa H. M.
    Abdelhamid, Mahmoud M. H.
    Naeem, Mohamed Ahmed
    Mekhemer, Gamal A. H.
    Sidhom, Peter A. A.
    Sayed, Shaban R. M.
    Pare, Paul W.
    Hegazy, Mohamed-Elamir F.
    PLOS ONE, 2023, 18 (07):